Repligen Corporation (RGEN)
USD 147.34
(-6.83%)
USD 147.34
(-6.83%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 261.12 Million USD | -14.95% |
| 2022 | 259.76 Million USD | 19.08% |
| 2021 | 218.14 Million USD | 56.03% |
| 2020 | 139.8 Million USD | 21.5% |
| 2019 | 115.06 Million USD | 40.17% |
| 2018 | 82.09 Million USD | 36.41% |
| 2017 | 60.18 Million USD | 57.51% |
| 2016 | 38.2 Million USD | 25.52% |
| 2015 | 30.43 Million USD | 33.72% |
| 2014 | 22.76 Million USD | 13.58% |
| 2013 | 20.04 Million USD | -15.49% |
| 2012 | 23.71 Million USD | 15.42% |
| 2011 | 20.54 Million USD | -3.22% |
| 2010 | 21.23 Million USD | 13.51% |
| 2009 | 18.7 Million USD | 182.2% |
| 2008 | -22.75 Million USD | -285.24% |
| 2007 | 12.28 Million USD | 16.11% |
| 2006 | 10.58 Million USD | 9.83% |
| 2005 | 9.63 Million USD | -29.2% |
| 2004 | 13.6 Million USD | 44.97% |
| 2003 | 9.38 Million USD | 19.01% |
| 2002 | 7.88 Million USD | -7.83% |
| 2001 | 8.55 Million USD | 30.46% |
| 2000 | 6.55 Million USD | 77.26% |
| 1999 | 3.7 Million USD | 27.59% |
| 1998 | 2.9 Million USD | -27.5% |
| 1997 | 4 Million USD | -78.49% |
| 1996 | 18.6 Million USD | -51.44% |
| 1995 | 38.3 Million USD | -13.93% |
| 1994 | 44.5 Million USD | 13.81% |
| 1993 | 39.1 Million USD | 58.3% |
| 1992 | 24.7 Million USD | 49.7% |
| 1991 | 16.5 Million USD | 251.06% |
| 1990 | 4.7 Million USD | 9.3% |
| 1989 | 4.3 Million USD | 4.88% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 65.31 Million USD | 4.22% |
| 2024 Q1 | 72.22 Million USD | 6.53% |
| 2023 FY | 220.94 Million USD | -14.95% |
| 2023 Q2 | 58.67 Million USD | -14.13% |
| 2023 Q4 | 67.79 Million USD | 2.66% |
| 2023 Q3 | 66.04 Million USD | 12.56% |
| 2023 Q1 | 68.32 Million USD | 6.18% |
| 2022 Q4 | 64.35 Million USD | 0.75% |
| 2022 FY | 259.76 Million USD | 19.08% |
| 2022 Q2 | 65.08 Million USD | -2.06% |
| 2022 Q1 | 66.45 Million USD | 8.63% |
| 2022 Q3 | 63.87 Million USD | -1.87% |
| 2021 Q1 | 46.7 Million USD | 8.45% |
| 2021 Q4 | 61.17 Million USD | 6.34% |
| 2021 Q3 | 57.52 Million USD | 9.1% |
| 2021 Q2 | 52.73 Million USD | 12.9% |
| 2021 FY | 218.14 Million USD | 56.03% |
| 2020 Q1 | 32.2 Million USD | -3.76% |
| 2020 Q4 | 43.06 Million USD | 28.66% |
| 2020 Q3 | 33.47 Million USD | 7.76% |
| 2020 FY | 139.8 Million USD | 21.5% |
| 2020 Q2 | 31.06 Million USD | -3.54% |
| 2019 Q2 | 28.93 Million USD | 27.91% |
| 2019 FY | 115.06 Million USD | 40.17% |
| 2019 Q1 | 22.61 Million USD | 7.32% |
| 2019 Q4 | 33.45 Million USD | 11.32% |
| 2019 Q3 | 30.05 Million USD | 3.89% |
| 2018 Q4 | 21.07 Million USD | 8.3% |
| 2018 FY | 82.09 Million USD | 36.41% |
| 2018 Q1 | 19.18 Million USD | -0.14% |
| 2018 Q2 | 22.37 Million USD | 16.6% |
| 2018 Q3 | 19.46 Million USD | -13.01% |
| 2017 Q1 | 10.92 Million USD | 2.99% |
| 2017 Q2 | 13.04 Million USD | 19.42% |
| 2017 Q3 | 16.99 Million USD | 30.31% |
| 2017 Q4 | 19.21 Million USD | 13.02% |
| 2017 FY | 60.18 Million USD | 57.51% |
| 2016 FY | 38.2 Million USD | 25.52% |
| 2016 Q1 | 8.55 Million USD | 8.26% |
| 2016 Q2 | 10.03 Million USD | 17.21% |
| 2016 Q3 | 9.01 Million USD | -10.14% |
| 2016 Q4 | 10.6 Million USD | 17.69% |
| 2015 Q3 | 7.44 Million USD | -0.6% |
| 2015 Q2 | 7.49 Million USD | -1.29% |
| 2015 Q4 | 7.9 Million USD | 6.11% |
| 2015 Q1 | 7.59 Million USD | 20.47% |
| 2015 FY | 30.43 Million USD | 33.72% |
| 2014 Q3 | 6.12 Million USD | 6.33% |
| 2014 Q1 | 4.58 Million USD | -4.26% |
| 2014 Q2 | 5.75 Million USD | 25.55% |
| 2014 Q4 | 6.3 Million USD | 2.97% |
| 2014 FY | 22.76 Million USD | 13.58% |
| 2013 Q2 | 5.43 Million USD | -1.12% |
| 2013 Q4 | 4.78 Million USD | 10.55% |
| 2013 Q1 | 5.49 Million USD | -1.87% |
| 2013 FY | 20.04 Million USD | -15.49% |
| 2013 Q3 | 4.33 Million USD | -20.23% |
| 2012 Q3 | 5.9 Million USD | -6.65% |
| 2012 Q4 | 5.59 Million USD | -5.2% |
| 2012 Q1 | 6.16 Million USD | 0.0% |
| 2012 Q2 | 6.32 Million USD | 2.51% |
| 2012 FY | 23.71 Million USD | 15.42% |
| 2011 FY | 20.54 Million USD | -3.22% |
| 2011 Q4 | - USD | -100.0% |
| 2011 Q2 | 5.8 Million USD | -6.69% |
| 2011 Q1 | 6.22 Million USD | 26.75% |
| 2011 Q3 | 5.56 Million USD | -4.11% |
| 2010 Q3 | 4.93 Million USD | 10.01% |
| 2010 FY | 21.23 Million USD | 13.51% |
| 2010 Q4 | 4.9 Million USD | -0.45% |
| 2010 Q1 | 5.4 Million USD | -2.78% |
| 2010 Q2 | 4.48 Million USD | -17.05% |
| 2009 Q3 | 5.36 Million USD | 9.53% |
| 2009 Q1 | 6.19 Million USD | 24.37% |
| 2009 FY | 18.7 Million USD | 182.2% |
| 2009 Q2 | 4.9 Million USD | -20.93% |
| 2009 Q4 | 5.55 Million USD | 3.57% |
| 2008 Q2 | 3.53 Million USD | -39.77% |
| 2008 FY | -22.75 Million USD | -285.24% |
| 2008 Q1 | 5.86 Million USD | 49.05% |
| 2008 Q3 | 3.99 Million USD | 13.1% |
| 2008 Q4 | 4.98 Million USD | 24.79% |
| 2007 FY | 12.28 Million USD | 16.11% |
| 2007 Q3 | 39.35 Million USD | 819.69% |
| 2007 Q2 | 4.27 Million USD | 35.94% |
| 2007 Q4 | 3.93 Million USD | -90.01% |
| 2007 Q1 | 3.14 Million USD | -5.59% |
| 2006 Q4 | 3.33 Million USD | 9.48% |
| 2006 FY | 10.58 Million USD | 9.83% |
| 2006 Q1 | 3.01 Million USD | 16.9% |
| 2006 Q2 | 2.75 Million USD | -8.49% |
| 2006 Q3 | 3.04 Million USD | 10.51% |
| 2005 FY | 9.63 Million USD | -29.2% |
| 2005 Q4 | 2.57 Million USD | -1.18% |
| 2005 Q3 | 2.6 Million USD | 9.28% |
| 2005 Q2 | 2.38 Million USD | -5.34% |
| 2005 Q1 | 2.52 Million USD | 10.47% |
| 2004 Q2 | 2.41 Million USD | -47.39% |
| 2004 Q1 | 4.59 Million USD | 66.17% |
| 2004 Q3 | 2.41 Million USD | -0.23% |
| 2004 Q4 | 2.28 Million USD | -5.44% |
| 2004 FY | 13.6 Million USD | 44.97% |
| 2003 Q2 | 3.33 Million USD | 17.72% |
| 2003 FY | 9.38 Million USD | 19.01% |
| 2003 Q4 | 2.76 Million USD | -5.02% |
| 2003 Q3 | 2.91 Million USD | -12.57% |
| 2003 Q1 | 2.82 Million USD | 29.66% |
| 2002 Q4 | 2.18 Million USD | -3.6% |
| 2002 FY | 7.88 Million USD | -7.83% |
| 2002 Q1 | 2.16 Million USD | 29.29% |
| 2002 Q2 | 2.1 Million USD | -2.37% |
| 2002 Q3 | 2.26 Million USD | 7.32% |
| 2001 Q4 | 1.67 Million USD | -16.88% |
| 2001 Q3 | 2.01 Million USD | -1.61% |
| 2001 Q2 | 2.04 Million USD | -7.3% |
| 2001 Q1 | 2.2 Million USD | -11.43% |
| 2001 FY | 8.55 Million USD | 30.46% |
| 2000 Q3 | 2.04 Million USD | 7.73% |
| 2000 Q2 | 1.9 Million USD | 14.64% |
| 2000 FY | 6.55 Million USD | 77.26% |
| 2000 Q1 | 1.65 Million USD | -30.89% |
| 2000 Q4 | 2.48 Million USD | 21.5% |
| 1999 Q2 | 1 Million USD | -9.09% |
| 1999 FY | 3.7 Million USD | 27.59% |
| 1999 Q1 | 1.1 Million USD | 37.5% |
| 1999 Q4 | 2.4 Million USD | 50.0% |
| 1999 Q3 | 1.6 Million USD | 60.0% |
| 1998 Q2 | 1 Million USD | 42.86% |
| 1998 Q1 | 700 Thousand USD | -12.5% |
| 1998 Q3 | 900 Thousand USD | -10.0% |
| 1998 FY | 2.9 Million USD | -27.5% |
| 1998 Q4 | 800 Thousand USD | -11.11% |
| 1997 Q4 | 800 Thousand USD | 14.29% |
| 1997 Q3 | 700 Thousand USD | -12.5% |
| 1997 Q2 | 800 Thousand USD | -27.27% |
| 1997 Q1 | 1.1 Million USD | 10.0% |
| 1997 FY | 4 Million USD | -78.49% |
| 1996 FY | 18.6 Million USD | -51.44% |
| 1996 Q4 | 1 Million USD | 11.11% |
| 1996 Q3 | 900 Thousand USD | -18.18% |
| 1996 Q2 | 1.1 Million USD | -60.71% |
| 1996 Q1 | 2.8 Million USD | -39.13% |
| 1995 Q1 | 8.1 Million USD | -15.63% |
| 1995 FY | 38.3 Million USD | -13.93% |
| 1995 Q4 | 4.6 Million USD | -19.3% |
| 1995 Q3 | 5.7 Million USD | 3.64% |
| 1995 Q2 | 5.5 Million USD | -32.1% |
| 1994 FY | 44.5 Million USD | 13.81% |
| 1994 Q4 | 9.6 Million USD | 0.0% |
| 1994 Q2 | 11 Million USD | 6.8% |
| 1994 Q1 | 10.3 Million USD | -9.65% |
| 1994 Q3 | 9.6 Million USD | -12.73% |
| 1993 Q3 | 11.5 Million USD | 1.77% |
| 1993 Q4 | 11.4 Million USD | -0.87% |
| 1993 Q2 | 11.3 Million USD | 14.14% |
| 1993 Q1 | 9.9 Million USD | -2.94% |
| 1993 FY | 39.1 Million USD | 58.3% |
| 1992 Q3 | 10.2 Million USD | 15.91% |
| 1992 Q4 | 10.2 Million USD | 0.0% |
| 1992 FY | 24.7 Million USD | 49.7% |
| 1992 Q1 | 5.7 Million USD | -49.11% |
| 1992 Q2 | 8.8 Million USD | 54.39% |
| 1991 Q2 | 1 Million USD | -92.31% |
| 1991 Q1 | 13 Million USD | 983.33% |
| 1991 FY | 16.5 Million USD | 251.06% |
| 1991 Q3 | 1.2 Million USD | 20.0% |
| 1991 Q4 | 11.2 Million USD | 833.33% |
| 1990 Q2 | 1.2 Million USD | 107.89% |
| 1990 Q4 | 1.2 Million USD | 9.09% |
| 1990 FY | 4.7 Million USD | 9.3% |
| 1990 Q3 | 1.1 Million USD | -8.33% |
| 1990 Q1 | -15.2 Million USD | 0.0% |
| 1989 FY | 4.3 Million USD | 4.88% |
| 1989 Q4 | - USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 Q2 | - USD | 100.0% |
| 1989 Q1 | -11.9 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 104.27 Million USD | -150.43% |
| AngioDynamics, Inc. | 252.41 Million USD | -3.449% |
| AtriCure, Inc. | 327.05 Million USD | 20.159% |
| Avinger, Inc. | 18.63 Million USD | -1301.025% |
| Azenta, Inc. | 336.26 Million USD | 22.346% |
| BioLife Solutions, Inc. | 117.57 Million USD | -122.087% |
| The Cooper Companies, Inc. | 1.82 Billion USD | 85.69% |
| Daxor Corporation | 1.28 Million USD | -20292.03% |
| Ekso Bionics Holdings, Inc. | 24.19 Million USD | -979.422% |
| Femasys Inc. | 15.2 Million USD | -1617.879% |
| GlucoTrack, Inc. | 7.1 Million USD | -3575.718% |
| Harvard Bioscience, Inc. | 58.58 Million USD | -345.747% |
| Hologic, Inc. | 1.34 Billion USD | 80.589% |
| ICU Medical, Inc. | 717.04 Million USD | 63.584% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 91.186% |
| KORU Medical Systems, Inc. | 26.1 Million USD | -900.17% |
| LeMaitre Vascular, Inc. | 90.33 Million USD | -189.054% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 218926.103% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 218926.103% |
| Masimo Corporation | 867 Million USD | 69.882% |
| Microbot Medical Inc. | 9.85 Million USD | -2549.65% |
| Meihua International Medical Technologies Co., Ltd. | 18.42 Million USD | -1317.601% |
| Merit Medical Systems, Inc. | 459.92 Million USD | 43.225% |
| Nephros, Inc. | 9.78 Million USD | -2568.878% |
| NovoCure Limited | 613.92 Million USD | 57.467% |
| NEXGEL, Inc. | 4.09 Million USD | -6275.073% |
| NEXGEL, Inc. | 4.09 Million USD | -6275.073% |
| Singular Genomics Systems, Inc. | 102.24 Million USD | -155.395% |
| OraSure Technologies, Inc. | 125.34 Million USD | -108.328% |
| Pro-Dex, Inc. | 7.37 Million USD | -3439.211% |
| Pulse Biosciences, Inc. | 43.57 Million USD | -499.263% |
| Predictive Oncology Inc. | 15.22 Million USD | -1614.583% |
| Precision Optics Corporation, Inc. | 8.52 Million USD | -2964.065% |
| QuidelOrtho Corporation | 1.35 Billion USD | 80.733% |
| Sanara MedTech Inc. | 61.12 Million USD | -327.18% |
| STAAR Surgical Company | 224.55 Million USD | -16.285% |
| Sharps Technology, Inc. | 10.12 Million USD | -2478.572% |
| Utah Medical Products, Inc. | 13.26 Million USD | -1869.105% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 85.445% |
| Jin Medical International Ltd. | 3.91 Million USD | -6565.43% |